Stellar signs distributor for Uracyst in Portugal
May 5, 2010 by leonardzehr · Leave a Comment
Stellar Pharmaceuticals’ (OTCBB: SLXCF) Uracyst drug for interstitial cystitis/painful bladder syndrome will be distributed in Portugal by CPH Companhia Portuguesa Higiene, a specialty pharma company with a major focus in urology, the primary target market for Uracyst. “Expanding the global licensing of Uracyst is a major growth driver for Stellar,” CEO, Peter Riehl, said in [...]
Listen to BioTuesdays 
